OMER EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Omeros Corporation Investors with Losses to Inquire About Class Action Investigation - OMERPRNewsWire • 12/20/21
Do Options Traders Know Something About Omeros (OMER) Stock We Don't?Zacks Investment Research • 12/15/21
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Omeros Corporation and Encourages Investors with Losses to Contact the FirmNewsfile Corp • 12/04/21
Omeros Announces Agreement to Sell OMIDRIA® Franchise to Rayner Surgical in a Transaction Valued in Excess of $1 BillionBusiness Wire • 12/02/21
Omeros Corporation (OMER) CEO Greg Demopulos on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/10/21
Omeros Announces Results From Nearly Three-Year Follow-up of Patients in Phase 2 IgA Nephropathy TrialBusiness Wire • 11/05/21
Omeros' Narsoplimab Stabilized Kidney Function and Reduced Urinary Complement Proteins in a Patient with IgA VasculitisBusiness Wire • 11/05/21
Wall Street Analysts See a 192% Upside in Omeros (OMER): Can the Stock Really Move This High?Zacks Investment Research • 11/04/21
Omeros Corporation to Announce Third Quarter Financial Results on November 9, 2021Business Wire • 11/04/21
Analysts Estimate Omeros (OMER) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 11/01/21
Omeros Receives Complete Response Letter from FDA for Biologics License Application for Narsoplimab in the Treatment of HSCT-TMABusiness Wire • 10/18/21
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMERPRNewsWire • 10/16/21
OMEROS ALERT: Bragar Eagel & Squire, P.C. is Investigating Omeros Corporation on Behalf of Omeros Stockholders and Encourages Investors to Contact the FirmBusiness Wire • 10/08/21